-
Topological Embedding of Human Brain Networks with Applications to Dynamics of Temporal Lobe Epilepsy
Authors:
Moo K. Chung,
Ji Bi Che,
Veena A. Nair,
Camille Garcia Ramos,
Jedidiah Ray Mathis,
Vivek Prabhakaran,
Elizabeth Meyerand,
Bruce P. Hermann,
Jeffrey R. Binder,
Aaron F. Struck
Abstract:
We introduce a novel, data-driven topological data analysis (TDA) approach for embedding brain networks into a lower-dimensional space in quantifying the dynamics of temporal lobe epilepsy (TLE) obtained from resting-state functional magnetic resonance imaging (rs-fMRI). This embedding facilitates the orthogonal projection of 0D and 1D topological features, allowing for the visualization and model…
▽ More
We introduce a novel, data-driven topological data analysis (TDA) approach for embedding brain networks into a lower-dimensional space in quantifying the dynamics of temporal lobe epilepsy (TLE) obtained from resting-state functional magnetic resonance imaging (rs-fMRI). This embedding facilitates the orthogonal projection of 0D and 1D topological features, allowing for the visualization and modeling of the dynamics of functional human brain networks in a resting state. We then quantify the topological disparities between networks to determine the coordinates for embedding. This framework enables us to conduct a coherent statistical inference within the embedded space. Our results indicate that brain network topology in TLE patients exhibits increased rigidity in 0D topology but more rapid flections compared to that of normal controls in 1D topology.
△ Less
Submitted 13 May, 2024;
originally announced May 2024.
-
Network-based Biased Tree Ensembles (NetBiTE) for Drug Sensitivity Prediction and Drug Sensitivity Biomarker Identification in Cancer
Authors:
Ali Oskooei,
Matteo Manica,
Roland Mathis,
Maria Rodriguez Martinez
Abstract:
We present the Network-based Biased Tree Ensembles (NetBiTE) method for drug sensitivity prediction and drug sensitivity biomarker identification in cancer using a combination of prior knowledge and gene expression data. Our devised method consists of a biased tree ensemble that is built according to a probabilistic bias weight distribution. The bias weight distribution is obtained from the assign…
▽ More
We present the Network-based Biased Tree Ensembles (NetBiTE) method for drug sensitivity prediction and drug sensitivity biomarker identification in cancer using a combination of prior knowledge and gene expression data. Our devised method consists of a biased tree ensemble that is built according to a probabilistic bias weight distribution. The bias weight distribution is obtained from the assignment of high weights to the drug targets and propagating the assigned weights over a protein-protein interaction network such as STRING. The propagation of weights, defines neighborhoods of influence around the drug targets and as such simulates the spread of perturbations within the cell, following drug administration. Using a synthetic dataset, we showcase how application of biased tree ensembles (BiTE) results in significant accuracy gains at a much lower computational cost compared to the unbiased random forests (RF) algorithm. We then apply NetBiTE to the Genomics of Drug Sensitivity in Cancer (GDSC) dataset and demonstrate that NetBiTE outperforms RF in predicting IC50 drug sensitivity, only for drugs that target membrane receptor pathways (MRPs): RTK, EGFR and IGFR signaling pathways. We propose based on the NetBiTE results, that for drugs that inhibit MRPs, the expression of target genes prior to drug administration is a biomarker for IC50 drug sensitivity following drug administration. We further verify and reinforce this proposition through control studies on, PI3K/MTOR signaling pathway inhibitors, a drug category that does not target MRPs, and through assignment of dummy targets to MRP inhibiting drugs and investigating the variation in NetBiTE accuracy.
△ Less
Submitted 26 April, 2019; v1 submitted 18 August, 2018;
originally announced August 2018.
-
PIMKL: Pathway Induced Multiple Kernel Learning
Authors:
Matteo Manica,
Joris Cadow,
Roland Mathis,
María Rodríguez Martínez
Abstract:
Reliable identification of molecular biomarkers is essential for accurate patient stratification. While state-of-the-art machine learning approaches for sample classification continue to push boundaries in terms of performance, most of these methods are not able to integrate different data types and lack generalization power, limiting their application in a clinical setting. Furthermore, many meth…
▽ More
Reliable identification of molecular biomarkers is essential for accurate patient stratification. While state-of-the-art machine learning approaches for sample classification continue to push boundaries in terms of performance, most of these methods are not able to integrate different data types and lack generalization power, limiting their application in a clinical setting. Furthermore, many methods behave as black boxes, and we have very little understanding about the mechanisms that lead to the prediction. While opaqueness concerning machine behaviour might not be a problem in deterministic domains, in health care, providing explanations about the molecular factors and phenotypes that are driving the classification is crucial to build trust in the performance of the predictive system. We propose Pathway Induced Multiple Kernel Learning (PIMKL), a novel methodology to reliably classify samples that can also help gain insights into the molecular mechanisms that underlie the classification. PIMKL exploits prior knowledge in the form of a molecular interaction network and annotated gene sets, by optimizing a mixture of pathway-induced kernels using a Multiple Kernel Learning (MKL) algorithm, an approach that has demonstrated excellent performance in different machine learning applications. After optimizing the combination of kernels for prediction of a specific phenotype, the model provides a stable molecular signature that can be interpreted in the light of the ingested prior knowledge and that can be used in transfer learning tasks.
△ Less
Submitted 5 July, 2018; v1 submitted 29 March, 2018;
originally announced March 2018.
-
INtERAcT: Interaction Network Inference from Vector Representations of Words
Authors:
Matteo Manica,
Roland Mathis,
María Rodríguez Martínez
Abstract:
In recent years, the number of biomedical publications has steadfastly grown, resulting in a rich source of untapped new knowledge. Most biomedical facts are however not readily available, but buried in the form of unstructured text, and hence their exploitation requires the time-consuming manual curation of published articles. Here we present INtERAcT, a novel approach to extract protein-protein…
▽ More
In recent years, the number of biomedical publications has steadfastly grown, resulting in a rich source of untapped new knowledge. Most biomedical facts are however not readily available, but buried in the form of unstructured text, and hence their exploitation requires the time-consuming manual curation of published articles. Here we present INtERAcT, a novel approach to extract protein-protein interactions from a corpus of biomedical articles related to a broad range of scientific domains in a completely unsupervised way. INtERAcT exploits vector representation of words, computed on a corpus of domain specific knowledge, and implements a new metric that estimates an interaction score between two molecules in the space where the corresponding words are embedded. We demonstrate the power of INtERAcT by reconstructing the molecular pathways associated to 10 different cancer types using a corpus of disease-specific articles for each cancer type. We evaluate INtERAcT using STRING database as a benchmark, and show that our metric outperforms currently adopted approaches for similarity computation at the task of identifying known molecular interactions in all studied cancer types. Furthermore, our approach does not require text annotation, manual curation or the definition of semantic rules based on expert knowledge, and hence it can be easily and efficiently applied to different scientific domains. Our findings suggest that INtERAcT may increase our capability to summarize the understanding of a specific disease using the published literature in an automated and completely unsupervised fashion.
△ Less
Submitted 16 April, 2018; v1 submitted 9 January, 2018;
originally announced January 2018.
-
Inferring clonal composition from multiple tumor biopsies
Authors:
Matteo Manica,
Hyunjae Ryan Kim,
Roland Mathis,
Philippe Chouvarine,
Dorothea Rutishauser,
Laura De Vargas Roditi,
Bence Szalai,
Ulrich Wagner,
Kathrin Oehl,
Karim Saba,
Arati Pati,
Julio Saez-Rodriguez,
Angshumoy Roy,
Donald W. Parsons,
Peter J. Wild,
María Rodríguez Martínez,
Pavel Sumazin
Abstract:
Explicit accounting for copy number alterations can dramatically improve mutation frequency estimates, leading to more accurate phylogeny reconstructions and subclone characterizations.
Explicit accounting for copy number alterations can dramatically improve mutation frequency estimates, leading to more accurate phylogeny reconstructions and subclone characterizations.
△ Less
Submitted 22 November, 2019; v1 submitted 26 January, 2017;
originally announced January 2017.
